Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells

Roburic acid (ROB) is a naturally occurred tetracyclic triterpenoid, and the anticancer activity of this compound has not been reported. Docetaxel (DOC) is the first-line chemotherapeutic agent for advanced stage prostate cancer but toxic side effects and drug resistance limit its clinical success....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao, Xuetao, Xu, Wu, Mengshuo, Wu, Panpan, Sheng, Zhaojun, Liu, Wenfeng, Ma, Yan-Yan, Zhao, Den-Gao, Zhang, Kun, Li, Dongli, Zheng, Xi, Goodin, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741252/
https://www.ncbi.nlm.nih.gov/pubmed/34986722
http://dx.doi.org/10.1080/14756366.2021.2018684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741252/
https://www.ncbi.nlm.nih.gov/pubmed/34986722
http://dx.doi.org/10.1080/14756366.2021.2018684

Ejemplares similares